While semaglutide itself does not cause significant hepatotoxicity, patients with pre-existing liver disease, those who consume 3 or more alcoholic drinks every day, or individuals taking other potentially hepatotoxic medications should consult their healthcare provider before regular acetaminophen use
For someone already close to frailty thresholds, a 1 to 2 kg hit to lean mass can dramatically reduce chair-stand time and raise the fall risk, which is why the quality of weight loss becomes extremely important in these patients
Beyond appetite suppression, GLP-1 medications improve how your body regulates blood sugar and may increase metabolic rate
Real-world effectiveness ultimately depends not just on pharmacological potency but on consistent, correct usage
Use of GLP-1 Drugs to Treat Overweight or Obesity Increased 587 Percent from 2019 to 2024, According to New FAIR Health Study News provided by FAIR Health May 27, 2025, 08:11 ET GLP-1 Prescriptions Increased 364 Percent for All Adults, and 588 Percent for Younger Adults Bariatric Surgeries Declined 42 Percent NEW YORK, May 27, 2025 /PRNewswire/ -- Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR Health data
Genetic information is educational context for that conversation
